This English-language Master’s programme is highly interdisciplinary and geared toward contemporary biomedical research and related markets such as biotechnology and biomedicine. The curriculum integrates core subjects from medicine, cell biology, histology, biochemistry and pathology with up‑to‑date topics in molecular and developmental biology to provide a comprehensive perspective on translational medicine and innovative therapeutic approaches.
The course is designed to develop both theoretical understanding and practical research skills. You will learn to design and evaluate experiments, handle a range of laboratory techniques, and critically assess scientific evidence. Emphasis is placed on information literacy, scientific communication in English (oral and written), teamwork, and an awareness of the ethical, social, economic and legal dimensions of biomedical research—skills that are valuable for careers in research, industry and other biomedical fields.
Key competencies (requirements)
This master’s curriculum is built from ten consecutive modules delivered over three semesters, together awarding a total of 90 credit points. The modules are compulsory (no electives), and the sequence is designed to build knowledge and skills step by step. At the end of the program you are conferred the Master of Science in Stem Cell Medicine. The structure emphasises a coherent, progressive learning path while allowing individual arrangements that give students notable flexibility and mobility within the programme.
Although there are no elective courses, the programme’s design supports breadth and depth by integrating theoretical foundations with applied components. Modules are organised so that earlier units establish core concepts and methodologies, which later modules expand into applied and translational contexts. The built‑in flexibility makes it feasible for international students to organise study periods, research stays or tailored practical experiences within the framework of the ten modules.
Typical module themes and expected learning outcomes
Program facts (concise)
This Master’s program looks for applicants with a relevant first university degree and a strong practical and theoretical background in cell and molecular biology. Acceptable undergraduate subjects include molecular medicine, human medicine, veterinary medicine, dentistry, pharmacy and comparable specialised programmes — the examination board will evaluate and confirm whether other related degrees are acceptable as equivalents.
There is a clear credit requirement: a completed Bachelor’s degree with a scope of 210 ECTS is required for direct admission. Applicants who hold degrees with 180–209 ECTS may be offered conditional admission; degrees with fewer than 180 ECTS are not eligible. International applicants should verify that their previous degree is recognised as equivalent under these rules.
In addition to academic preparation, applicants must demonstrate strong knowledge of cell biology and molecular biology (both theoretical and practical) and must have at least one year of first professional work experience. Sufficient English language proficiency is also required — refer to the programme’s official information for the specific English tests and minimum scores accepted.
Admission requirements (bullet points)
Winter Semester (International)
15 May 2026
Winter Semester (EU/EEA)
15 July 2026
Graduates are prepared for roles in academic and industrial research settings where stem cell and translational expertise is required, such as research laboratories, translational research groups, biotechnology and biopharma companies, clinical research organisations, and regulatory or quality control functions. The programme’s emphasis on practical laboratory skills, experimental design and scientific communication also provides a solid foundation for doctoral study (PhD).
Because instruction and assessment are in English and the curriculum includes international project components, alumni are positioned to pursue opportunities both within Germany and internationally in research, development and product‑oriented roles in the biomedical sector.
Technical University of Munich — München
Technical University of Munich — München
Hochschule Fresenius - University of Applied Sciences — Berlin
Dresden International University — Dresden